Can less weight loss be better weight loss?
This morning at ADA, Eli Lilly released data on the Believe Phase 2b study of Bimagrumab in combination with a GLP-1 (Semaglutide)
The goal: lose only fat
Approach: anorectic + anabolic
The Mayo Clinic is calling Alzheimer's Type 3 Diabetes
I bet you know someone who is suffering from it.
The current treatments are not lowering the rates of Alzheimer's.
In fact, rates of the disease continue to rise every year.
There’s a reason….
THREAD
New @NEJM
A GLP-1 drug (semaglutide) led to lack of need for insulin in 7 of 10 people with recent onset Type 1 (autoimmune) diabetes, and the other 3 of 10 had eliminated need for insulin w/ meals
https://t.co/oKCznW3iaW
Since 2000, the prevalence of type 1 diabetes has increased at 4 TIMES the rate of global population growth.
We worked with @JDRF, @LifeforaChild, @ISPAD_org, and the @IntDiabetesFed to launch a tool showing the global impact of T1D.
Visit the T1D Index: https://t.co/HgKVt5BKYS
Empowering whole person health. Together with #Dexcom, we're expanding product capabilities and launching a pilot demonstrating the impact of CGM-powered insights for people with Type 2 diabetes. Learn more: https://t.co/jhAkzbN5KV
Today is #WorldDiabetesDay. To honor our Members, and all people living with Diabetes, @Livongo is taking over the Times Square video boards to share important #WDD messages. @Nasdaq@WDD
🌇 @Livongo’s Applied Health Signals platform leverages data science, technology, and teams of health coaches to create a new kind of personalized experience for people with chronic conditions. #LivongoIPO $LVGO
Today we’re thrilled to welcome @Livongo to our family of innovative companies! ⚕️ They’re a leading consumer digital health company using #AppliedHealthSignals to empower people with chronic conditions live better and healthier lives. #LivongoIPO
Livongo now integrates with Apple, Fitbit, Samsung smartwatches. Great work by the @Livongo Labs team as we make it easier for our Members to stay healthy. https://t.co/2iKrSk9lp9
.@Livongo gains approval by @CMSGov as an enrolled provider for Medicare Advantage members. The Livongo for Diabetes program will also now be available to Medicare Advantage members of @Cambia's regional health plans. Read more: https://t.co/sMixNr8kkJ